LABNEW (LAB) 24-Hour Volatility at 124.0%: Rebound Driven by Whale Accumulation Followed by Pullback, Manipulation Concerns Trigger Sell-Off
Bitget Pulse2026/05/15 16:02Volatility Overview
In the past 24 hours, LABNEW (LAB) price rebounded from a low of $2.88837 to a high of $6.47104, currently trading at $4.02118, with a price swing of up to 124.0%. 24-hour trading volume surged to $206 million - $238 million, indicating a net capital inflow.
Brief Analysis of the Cause of the Anomaly
- Whale accumulation drives rebound: On-chain monitoring shows several new wallets withdrawing about 30% of the circulating supply (approximately 100 million LAB, valued at over $500 million) from exchanges, with an average cost of around $4.90, directly triggering the price rebound from the bottom.
- Trading volume and net capital inflow amplify volatility: 24-hour trading volume reached the $55-90 million level, accompanied by obvious net capital inflow, further pushing prices higher.
- Team distribution and manipulation concerns lead to pullback: The team distributed 100 million LAB tokens to 10 wallets. Combined with on-chain analysis linking RIVER team to cross-project manipulation and a delisting warning from ZachXBT, the price plummeted over 50% intraday.
Market View and Outlook
The mainstream sentiment in the market and community remains cautious. Key concerns include pump-and-dump risks and potential delisting. Analysts highlight that high Binance open interest creates manipulation risks, and the price may see a 40-50% correction. It is advised to watch the subsequent movements of whales and overall liquidity.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.